Milestone Scientific to Present at the Q1 Virtual Investor Summit

Rhea-AI Summary

Milestone Scientific Inc. (NYSE: MLSS) announces that CEO Arjan Haverhals will present at the Q1 Virtual Investor Summit on March 24, 2021, at 11:00 AM ET. The summit will be held from March 23-25 and connects smallcap and microcap companies to investors. The event features 100 companies and over 300 investors. Milestone Scientific specializes in computerized drug delivery technologies, ensuring precise and virtually painless injections. For registration details, visit www.investorsummitgroup.com.

ROSELAND, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that Arjan Haverhals, CEO of Wand Dental and President of Milestone Scientific, will be presenting at the Q1 Virtual Investor Summit on March 24^th.

Event	Q1 Investor Summit
Date	March 23-25th, 2021
Presentation	March 24th @ 11:00AM ET
Location	https://zoom.us/webinar/register/WN_zq3yW7kuQouOPE28oFuSvw

About The Investor Summit
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q1 Investor Summit will take place virtually, featuring 100 companies and over 300 institutional and retail investors. 

To request complimentary investor registration: please visit our website at www.investorsummitgroup.com 

About Milestone Scientific Inc.

Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone's computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone’s proprietary DPS Dynamic Pressure Sensing technology^® is our technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections. For more information please visit our website: www.milestonescientific.com. 

Contact: 
Brittney Blocker at brittney@investorsummitgroup.com

Wire Service Contact
InvestorWire (IW)
Los Angeles, California
www.InvestorWire.com
212.418.1217 Office
Editor@InvestorWire.com

Contact:
David Waldman or Natalya Rudman
Crescendo Communications, LLC
Email: mlss@crescendo-ir.com
Tel: 212-671-1020

FAQ

When is Milestone Scientific's presentation at the Q1 Investor Summit?

Milestone Scientific's presentation is scheduled for March 24, 2021, at 11:00 AM ET.

What are the dates of the Q1 Investor Summit?

The Q1 Investor Summit will take place from March 23 to March 25, 2021.

Where can I register for the Q1 Investor Summit?

You can register for the Q1 Investor Summit at www.investorsummitgroup.com.

What is Milestone Scientific known for?

Milestone Scientific is known for developing computerized drug delivery instruments that provide precise and virtually painless injections.

What technology does Milestone Scientific use for injections?

Milestone Scientific uses its proprietary DPS Dynamic Pressure Sensing technology® for advanced injection procedures.